肌少症是头颈癌放化疗后长期依赖喂养管的强决定因素
本研究对128例接受根治性放化疗的头颈癌患者进行回归分析,评估骨骼肌质量指数(SMI)与长期(>90天)喂养管依赖的关联。结果显示48%患者出现长期依赖,较低的SMI在多变量分析中增加依赖风险(风险比1.08;结论认为肌少症 contribute 于长期喂养管依赖风险,且可能是治疗前可干预因素。
要点
- 低骨骼肌质量指数(SMI)与头颈癌放化疗后长期喂养管依赖风险独立相关。
- 多变量分析显示SMI每降低一个单位,长期依赖风险增加8%(RR 1.08,95%CI 1.02-1.14)。
- 肌少症可能是治疗前可干预因素,值得探索以优化患者状况。
核心结论
- 肌少症 contribute 于接受根治性放化疗的头颈癌患者长期喂养管依赖的风险。
- 肌少症可能是治疗前可干预因素,应作为优化患者状况的探索靶点。
研究设计与样本
- 对128例接受根治性放化疗的头颈癌患者进行回归分析,评估SMI与长期(>90天)喂养管依赖的关联。
关键数值与推荐
- 长期喂养管依赖定义为>90天。
- SMI作为肌少症的测量指标。
- 多变量分析校正因素包括体重指数、异常饮食和社会经济状况。
临床怎么用
- 对头颈癌根治性放化疗患者,治疗前评估骨骼肌质量指数(SMI)有助于识别长期喂养管依赖高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia might be a relevant lead for optimization of the condition of patients with head and neck cancer (HNC) before chemoradiotherapy (CRT) to prevent long-term functional swallowing impairment, such as feeding tube dependency. METHODS: Regression analyses were performed to assess the association between skeletal muscle mass index (SMI), as a measure of sarcopenia, and prolonged (>90 days) feeding tube dependency in 128 patients with HNC treated with primary CRT. RESULTS: Sixty-one patients (48%) became prolonged feeding tube-dependent. Lower SMI increased the risk of prolonged feeding tube dependency in multivariable analysis (risk ratio 1.08; 95% confidence interval 1.02-1.14, P = .01) adjusted for body mass index, abnormal diet, and socioeconomic status. CONCLUSIONS: Sarcopenia contributes to the risk of prolonged feeding tube dependency of patients with HNC treated with primary CRT. As sarcopenia might be a modifiable factor prior to treatment, it should be explored as a target for pretreatment patients' condition.
引用
- Karsten RT, Al-Mamgani A, Bril SI, et al. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer. Head Neck. 2019. PMID: 31472000. doi:10.1002/hed.25938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。